The effect of Madopar on the pharmacokinetics of ropinirole in healthy Chinese volunteers

Journal of Pharmaceutical and Biomedical Analysis

Volumn 43, Issue 2, 2007, Pages 774-778

  Wen, Ai Dong ^a   Jia, Yan Yan ^a   Luo, Xiao Xing ^b   Bi, Lin Lin ^a   Chen, Xiao Yan ^c   Zhong, Da Fang ^c  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Benserazide; HPLC MS MS; Levodopa; Madopar; Pharmacokinetics; Ropinirole

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; DIPHENHYDRAMINE; DOMPERIDONE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; PLACEBO; ROPINIROLE; THEOPHYLLINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; CHINESE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG METABOLISM; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; MALE; MONOTHERAPY; NEUROLOGIC DISEASE; NORMAL HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE DRUG DOSE; TABLET; TANDEM MASS SPECTROMETRY;

ADULT; ANTIPARKINSON AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BENSERAZIDE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; DOPA DECARBOXYLASE; DRUG COMBINATIONS; DRUG INTERACTIONS; ENZYME INHIBITORS; FEMALE; HUMANS; INDOLES; LEVODOPA; LINEAR MODELS; MALE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 33845635320     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2006.08.001     Document Type: Article

References (14)

1. Reichmann H., Angersbach D., and Buchwald B. Nervenarzt 76 (2005) 1239-1242
2. Bogan R.K., Fry J.M., Schmidt M.H., Carson S.W., Ritchie S.Y., and TREAT RLS US Study Group. Mayo Clin. Proc. 81 (2006) 17-27
3. Perea E., Robbins B.V., and Hutto B. Am. J. Psychiat. 163 (2006) 547-548
4. Contin M., Martinelli P., Mochi M., Riva R., Albani F., and Baruzzi A. Mov. Disord. 20 (2005) 734-739
5. Ramji J.V., Keogh J.P., Blake T.J., Broom C., Chenery R.J., Citerone D.R., Lewis V.A., Taylor A.C., and Yeulet S.E. Xenobiotica 29 (1999) 311-325
6. Hubble J., Koller W.C., Atchison P., Taylor A.C., Citerone D.R., Zussman B.D., Friedman C.J., and Hawker N. J. Clin. Pharmacol. 40 (2000) 641-646
7. Kaye C.M., and Nicholls B. Clin. Pharmacokinet. 39 (2000) 243-254
8. Taylor A.C., Beerahee A., Citerone D.R., Cyronak M.J., Leigh T.J., Fitzpatrick K.L., Lopez-Gil A., Vakil S.D., Burns E., and Lennox G. Pharmacotherapy 19 (1999) 150-156
9. Baas H., Zehrden F., Selzer R., Kohnen R., Loetsch J., and Harder S. Clin. Pharmacokinet. 40 (2001) 383-393
10. Bhatt J., Jangid A., Shetty R., Shah B., Kambli S., Subbaiah G., and Singh S. J. Pharm. Biomed. Anal. 40 (2006) 1202-1208
11. Bloomer J.C., Clarke S.C., and Chenery R.J. Drug Metab. Dispos. 25 (1997) 840-844
12. Mey C.D., Enterling D., Meineke I., and Yeulet S. Br. J. Clin. Pharmacol. 132 (1991) 438-483
13. Thalamas C., Taylor A., Brefel-Courbon C., Eagle S., Fitzpatrick K., and Rascol O. Eur. J. Clin. Pharmacol. 55 (1999) 299-303
14. Nyholm D. Clin. Pharmacokinet. 45 (2006) 109-136